Table of Contents

1 Report Overview

• 1.1 Study Scope
• 1.2 Key Market Segments
• 1.3 Players Covered
• 1.4 Market Analysis by Type
  • 1.4.1 Global Romiplostim Market Size Growth Rate by Type (2014-2025)
  • 1.4.2 250 μg/0.5 mL
  • 1.4.3 500 μg/1 mL
• 1.5 Market by Application
  • 1.5.1 Global Romiplostim Market Share by Application (2014-2025)
  • 1.5.2 Adults
  • 1.5.3 Pediatric patients
• 1.6 Study Objectives
• 1.7 Years Considered

2 Global Growth Trends

• 2.1 Romiplostim Market Size
• 2.2 Romiplostim Growth Trends by Regions
  • 2.2.1 Romiplostim Market Size by Regions (2014-2025)
  • 2.2.2 Romiplostim Market Share by Regions (2014-2019)
• 2.3 Industry Trends
  • 2.3.1 Market Top Trends
  • 2.3.2 Market Drivers
  • 2.3.3 Market Opportunities

3 Market Share by Key Players

• 3.1 Romiplostim Market Size by Manufacturers
  • 3.1.1 Global Romiplostim Revenue by Manufacturers (2014-2019)
  • 3.1.2 Global Romiplostim Revenue Market Share by Manufacturers (2014-2019)
  • 3.1.3 Global Romiplostim Market Concentration Ratio (CR5 and HHI)
• 3.2 Romiplostim Key Players Head office and Area Served
• 3.3 Key Players Romiplostim Product/Solution/Service
• 3.4 Date of Enter into Romiplostim Market
• 3.5 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type and Application

• 4.1 Global Romiplostim Market Size by Type (2014-2019)
• 4.2 Global Romiplostim Market Size by Application (2014-2019)

5 United States

• 5.1 United States Romiplostim Market Size (2014-2019)
• 5.2 Romiplostim Key Players in United States
• 5.3 United States Romiplostim Market Size by Type
• 5.4 United States Romiplostim Market Size by Application

6 Europe

• 6.1 Europe Romiplostim Market Size (2014-2019)
• 6.2 Romiplostim Key Players in Europe
• 6.3 Europe Romiplostim Market Size by Type
• 6.4 Europe Romiplostim Market Size by Application

7 China

• 7.1 China Romiplostim Market Size (2014-2019)
• 7.2 Romiplostim Key Players in China
• 7.3 China Romiplostim Market Size by Type
• 7.4 China Romiplostim Market Size by Application

8 Japan

• 8.1 Japan Romiplostim Market Size (2014-2019)
• 8.2 Romiplostim Key Players in Japan
• 8.3 Japan Romiplostim Market Size by Type
• 8.4 Japan Romiplostim Market Size by Application

9 Southeast Asia

• 9.1 Southeast Asia Romiplostim Market Size (2014-2019)
• 9.2 Romiplostim Key Players in Southeast Asia
• 9.3 Southeast Asia Romiplostim Market Size by Type
• 9.4 Southeast Asia Romiplostim Market Size by Application

10 India

• 10.1 India Romiplostim Market Size (2014-2019)
• 10.2 Romiplostim Key Players in India
• 10.3 India Romiplostim Market Size by Type
• 10.4 India Romiplostim Market Size by Application

11 Central & South America

• 11.1 Central & South America Romiplostim Market Size (2014-2019)
• 11.2 Romiplostim Key Players in Central & South America
• 11.3 Central & South America Romiplostim Market Size by Type
• 11.4 Central & South America Romiplostim Market Size by Application

12 International Players Profiles

• 12.1 AMGEN
  • 12.1.1 AMGEN Company Details
  • 12.1.2 Company Description and Business Overview
  • 12.1.3 Romiplostim Introduction
  • 12.1.4 AMGEN Revenue in Romiplostim Business (2014-2019)
  • 12.1.5 AMGEN Recent Development

13 Market Forecast 2019-2025

• 13.1 Market Size Forecast by Regions
• 13.2 United States
• 13.3 Europe
• 13.4 China
• 13.5 Japan
• 13.6 Southeast Asia
• 13.7 India
• 13.8 Central & South America
• 13.9 Market Size Forecast by Product (2019-2025)
• 13.10 Market Size Forecast by Application (2019-2025)

14 Analyst's Viewpoints/Conclusions

15 Appendix

• 15.1 Research Methodology
  • 15.1.1 Methodology/Research Approach
    • 15.1.1.1 Research Programs/Design
    • 15.1.1.2 Market Size Estimation
    • 12.1.1.3 Market Breakdown and Data Triangulation
  • 15.1.2 Data Source
    • 15.1.2.1 Secondary Sources
    • 15.1.2.2 Primary Sources
• 15.2 Disclaimer

Romiplostim (rINN, USAN) is a fusion protein analog of thrombopoietin, a hormone that regulates platelet production.
In 2018, the global Romiplostim market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

This report focuses on the global Romiplostim status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Romiplostim development in United States, Europe and China.

The key players covered in this study
AMGEN
...

Market segment by Type, the product can be split into
250 μg/0.5 mL
500 μg/1 mL

Market segment by Application, split into
Adults
Pediatric patients

Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America

The study objectives of this report are:
To analyze global Romiplostim status, future forecast, growth opportunity, key market and key players.
To present the Romiplostim development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.

In this study, the years considered to estimate the market size of Romiplostim are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.